US2017247329A1PendingUtilityA1

"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones"

Assignee: APOTEX TECH INCPriority: Jul 3, 2009Filed: May 12, 2017Published: Aug 31, 2017
Est. expiryJul 3, 2029(~2.9 yrs left)· nominal 20-yr term from priority
A61P 35/00A61P 39/04A61P 25/00A61P 25/28A61P 13/00A61P 13/12A61P 11/00C07D 213/69C07D 211/88A61K 31/4412C07D 213/79C07D 211/86C07D 213/26C07D 401/06A61K 31/496A61K 31/4545C07D 213/74
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.

Claims

exact text as granted — not AI-modified
1 . A compound of Formula I: 
       
         
           
           
               
               
           
         
         wherein
 G 1  is H, C 1 -C 4  alkyl or CH 2 OH; 
 G 2  is (CH 2 ) n CF 2 R 3 , where n is 1, and R 3  is H or F; 
 G 3  is H or Ci-C4 alkyl; and 
 G 4  is H. 
 
       
     
     
         2 . (canceled) 
     
     
         3 . The compound of  claim 1  wherein R 3  is F. 
     
     
         4 .- 5 . (canceled) 
     
     
         6 . The compound of  claim 3  wherein G 1  is ethyl, and G 3  is H. 
     
     
         7 .- 10 . (canceled) 
     
     
         11 . A method of treating a medical condition related to a toxic concentration of iron, wherein the method comprises administering to a subject having or suspected of having a medical condition related to a toxic concentration of iron, an effect amount of a compound of formula 1. 
     
     
         12 . The method of  claim 11  wherein the medical condition related to a toxic concentration of iron is selected from the group consisting of cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.

Join the waitlist — get patent alerts

Track US2017247329A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.